119 related articles for article (PubMed ID: 7479585)
1. Crown-rump length in aneuploid fetuses: implications for first-trimester biochemical screening for aneuploidies.
Macintosh MC; Brambati B; Chard T; Grudzinskas JG
Prenat Diagn; 1995 Aug; 15(8):691-4. PubMed ID: 7479585
[TBL] [Abstract][Full Text] [Related]
2. Biparietal diameter and crown-rump length in fetuses with Down's syndrome: implications for antenatal serum screening for Down's syndrome.
Wald NJ; Smith D; Kennard A; Palomaki GE; Salonen R; Holzgreve W; Pejtsik B; Coombes EJ; Mancini G; MacRae AR
Br J Obstet Gynaecol; 1993 May; 100(5):430-5. PubMed ID: 8518242
[TBL] [Abstract][Full Text] [Related]
3. Establishment and application of a normal range for nuchal translucency across the first trimester.
Scott F; Boogert A; Sinosich M; Anderson J
Prenat Diagn; 1996 Jul; 16(7):629-34. PubMed ID: 8843472
[TBL] [Abstract][Full Text] [Related]
4. The first trimester combined test for aneuploidies - a single center experience.
Veduta A; Vayna AM; Duta S; Panaitescu A; Popescu F; Bari M; Peltecu G; Nedelea F
J Matern Fetal Neonatal Med; 2018 Aug; 31(16):2091-2096. PubMed ID: 28553771
[TBL] [Abstract][Full Text] [Related]
5. Impact of bias in crown-rump length measurement at first-trimester screening for trisomy 21.
Kagan KO; Hoopmann M; Baker A; Huebner M; Abele H; Wright D
Ultrasound Obstet Gynecol; 2012 Aug; 40(2):135-9. PubMed ID: 22262465
[TBL] [Abstract][Full Text] [Related]
6. First-trimester growth restriction and fetal aneuploidy: the effect of type of aneuploidy and gestational age.
Bahado-Singh RO; Lynch L; Deren O; Morroti R; Copel JA; Mahoney MJ; Williams J
Am J Obstet Gynecol; 1997 May; 176(5):976-80. PubMed ID: 9166154
[TBL] [Abstract][Full Text] [Related]
7. Prediction of birth weight by fetal crown-rump length and maternal serum levels of pregnancy-associated plasma protein-A in the first trimester.
Leung TY; Sahota DS; Chan LW; Law LW; Fung TY; Leung TN; Lau TK
Ultrasound Obstet Gynecol; 2008 Jan; 31(1):10-4. PubMed ID: 18098339
[TBL] [Abstract][Full Text] [Related]
8. Frontomaxillary facial angle in screening for trisomy 21 at 11 + 0 to 13 + 6 weeks.
Borenstein M; Persico N; Kagan KO; Gazzoni A; Nicolaides KH
Ultrasound Obstet Gynecol; 2008 Jul; 32(1):5-11. PubMed ID: 18512854
[TBL] [Abstract][Full Text] [Related]
9. A mixture model of ductus venosus pulsatility index in screening for aneuploidies at 11-13 weeks' gestation.
Maiz N; Wright D; Ferreira AF; Syngelaki A; Nicolaides KH
Fetal Diagn Ther; 2012; 31(4):221-9. PubMed ID: 22614037
[TBL] [Abstract][Full Text] [Related]
10. Influence of medically assisted reproduction techniques on crown-rump length and biochemical markers of trisomy 21 in the first trimester of pregnancy.
Bonne S; Sauleau E; Sananes N; Akaladios C; Rongières C; Pirrello O
Fertil Steril; 2016 Feb; 105(2):410-6. PubMed ID: 26604071
[TBL] [Abstract][Full Text] [Related]
11. First-trimester screening in pregnancies conceived by assisted reproductive technology: significance of gestational dating by oocyte retrieval or sonographic measurement of crown-rump length.
Gjerris AC; Loft A; Pinborg A; Tabor A; Christiansen M
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):612-7. PubMed ID: 18816495
[TBL] [Abstract][Full Text] [Related]
12. Gestational length assignment based on last menstrual period, first trimester crown-rump length, ovulation, and implantation timing.
Mahendru AA; Wilhelm-Benartzi CS; Wilkinson IB; McEniery CM; Johnson S; Lees C
Arch Gynecol Obstet; 2016 Oct; 294(4):867-76. PubMed ID: 27469987
[TBL] [Abstract][Full Text] [Related]
13. First trimester risk assessment for trisomy 21 in twin pregnancies combining nuchal translucency and first trimester biochemical markers.
Prats P; Rodríguez I; Comas C; Puerto B
Prenat Diagn; 2012 Oct; 32(10):927-32. PubMed ID: 22752980
[TBL] [Abstract][Full Text] [Related]
14. Umbilical cord diameter at 11-14 weeks of gestation: relationship to nuchal translucency, ductus venous blood flow and chromosomal defects.
Axt-Fliedner R; Schwarze A; Kreiselmaier P; Krapp M; Smrcek J; Diedrich K
Fetal Diagn Ther; 2006; 21(4):390-5. PubMed ID: 16757918
[TBL] [Abstract][Full Text] [Related]
15. Cross-trimester repeated measures testing for Down's syndrome screening: an assessment.
Wright D; Bradbury I; Malone F; D'Alton M; Summers A; Huang T; Ball S; Baker A; Nix B; Aitken D; Crossley J; Cuckle H; Spencer K
Health Technol Assess; 2010 Jul; 14(33):1-80. PubMed ID: 20624355
[TBL] [Abstract][Full Text] [Related]
16. Lack of standardization in determining gestational age for prenatal screening.
Koster MP; Van Leeuwen-Spruijt M; Wortelboer EJ; Stoutenbeek P; Elvers LH; Loeber JG; Visser GH; Schielen PC
Ultrasound Obstet Gynecol; 2008 Oct; 32(5):607-11. PubMed ID: 18720453
[TBL] [Abstract][Full Text] [Related]
17. Crown-rump length audit plots with the use of operator-specific PAPP-A and β-hCG median MoM.
Sabria J; Guirado L; Miró I; Gómez-Roig MD; Borrell A
Prenat Diagn; 2017 Mar; 37(3):229-234. PubMed ID: 28006080
[TBL] [Abstract][Full Text] [Related]
18. The significance of fetal maxillary length in the first trimester screening for trisomy 21.
Unsal N; Ozat M; Kanat-Pektas M; Gungor T; Danisman N
Arch Gynecol Obstet; 2011 Jun; 283(6):1199-205. PubMed ID: 20505946
[TBL] [Abstract][Full Text] [Related]
19. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
20. Combined measurement of fetal nuchal translucency, maternal serum free beta-hCG, and pregnancy-associated plasma protein A for first-trimester Down's syndrome screening.
Tsai MS; Huang YY; Hwa KY; Cheng CC; Lee FK
J Formos Med Assoc; 2001 May; 100(5):319-25. PubMed ID: 11432311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
